Arcturus Therapeutics
ARCT5.7001.04% ( -0.060 )
Arcturus Therapeutics (ARCT)
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its techn...
- Open
- 5.750
- High
- 5.782
- Low
- 5.570
- Prev. Close
- 5.760
- Volume
- 283.12K
- Turnover
- 1.60M
- Avg Price
- 5.657
- Bid/Ask Ratio
- --
- Amplitude
- 3.68%
- 52wk High
- 24.170
- Volume Ratio
- 0.67
- Turnover Ratio
- 1.08%
Arcturus Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$20.60261.09%
Forecast & RatingBuy
13analysts
- Strong buy69.23%
- Buy7.69%
- Hold23.08%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 10 hours ago
Cut the Earnings Season Noise: From AI Washing to Real Cash in 10 Outlier Stocks
- Global Report · Jul 21 at 04:13 AM
The Value Chain Dictates the Outcome: From Defense Platforms to Biotech Aggregators
- Market Beat · Jul 21 at 02:13 AM
Amova Asset Management Americas Inc. Grows Stock Holdings in Arcturus Therapeutics Holdings Inc. $ARCT
- Simplywall · Jul 15 at 12:12 PM
How New Forensics and mRNA Partnerships at Thermo Fisher Scientific (TMO) Have Changed Its Investment Story
- Global Report · Jul 14 at 06:47 AM
Biotech Reorganizes While Industrials and Consumer Discretionary Navigate Pricing Pressures
- Simplywall · Jul 5 at 03:01 PM
How Investors May Respond To Thermo Fisher Scientific (TMO) Deepening Its Role In Late‑Stage mRNA Manufacturing
